BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 34043958)

  • 21. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.
    Venkataraman A; Kumar NP; Hanna LE; Putlibai S; Karthick M; Rajamanikam A; Sadasivam K; Sundaram B; Babu S
    EBioMedicine; 2021 Apr; 66():103317. PubMed ID: 33813138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process.
    Harwood R; Allin B; Jones CE; Whittaker E; Ramnarayan P; Ramanan AV; Kaleem M; Tulloh R; Peters MJ; Almond S; Davis PJ; Levin M; Tometzki A; Faust SN; Knight M; Kenny S;
    Lancet Child Adolesc Health; 2021 Feb; 5(2):133-141. PubMed ID: 32956615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paediatric inflammatory multisystem syndrome in Canada: population-based surveillance and role of SARS-CoV-2 linkage.
    El Tal T; Morin MP; Morris SK; Farrar DS; Berard RA; Kakkar F; Moore Hepburn C; Baerg K; Beaufils C; Bennett TL; Benseler SM; Beaudoin-Bussières G; Chan K; Cyr C; Dahdah N; Donner EJ; Drouin O; Edjoc R; Eljaouhari M; Embree JE; Farrell C; Finzi A; Forgie S; Giroux R; Kang KT; King M; Laffin Thibodeau M; Lang B; Laxer RM; Luu TM; McCrindle BW; Orkin J; Papenburg J; Pound CM; Price VE; Proulx-Gauthier JP; Purewal R; Sadarangani M; Salvadori MI; Thibeault R; Top KA; Viel-Thériault I; Haddad E; Scuccimarri R; Yeung RSM
    Pediatr Res; 2023 Nov; 94(5):1744-1753. PubMed ID: 37277605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland.
    Schöbi N; Sanchez C; Welzel T; Bamford A; Webb K; Rojo P; Tremoulet A; Atkinson A; Schlapbach LJ; Bielicki JA;
    BMJ Open; 2024 Apr; 14(4):e078137. PubMed ID: 38670610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nationwide observational study of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the Czech Republic.
    David J; Stara V; Hradsky O; Tuckova J; Slaba K; Jabandziev P; Sasek L; Huml M; Zidkova I; Pavlicek J; Palatova A; Klaskova E; Banszka K; Terifajova E; Vyhnanek R; Bloomfield M; Fingerhutova S; Dolezalova P; Prochazkova L; Chramostova G; Fencl F; Lebl J
    Eur J Pediatr; 2022 Oct; 181(10):3663-3672. PubMed ID: 35987943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist.
    Papadopoulou C; Al Obaidi M; Moraitis E; Compeyrot-Lacassagne S; Eleftheriou D; Brogan P
    Rheumatology (Oxford); 2021 Feb; 60(2):911-917. PubMed ID: 33197261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year.
    Ward JL; Harwood R; Smith C; Kenny S; Clark M; Davis PJ; Draper ES; Hargreaves D; Ladhani S; Linney M; Luyt K; Turner S; Whittaker E; Fraser LK; Viner RM
    Nat Med; 2022 Jan; 28(1):193-200. PubMed ID: 34931076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paediatric inflammatory multisystem syndrome - temporally associated with SARS-CoV-2 (PIMS-TS) - a German single centre real-life evaluation of the Swiss and UK consensus statements.
    Jenke A; Steinmetz M
    Cardiol Young; 2023 Apr; 33(4):546-550. PubMed ID: 35546290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 [PIMS-TS] in a Patient Receiving Infliximab Therapy for Inflammatory Bowel Disease.
    Meredith J; Khedim CA; Henderson P; Wilson DC; Russell RK
    J Crohns Colitis; 2021 Apr; 15(4):687-691. PubMed ID: 32997749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review.
    Hoste L; Van Paemel R; Haerynck F
    Eur J Pediatr; 2021 Jul; 180(7):2019-2034. PubMed ID: 33599835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Publishing in pandemic times: A bibliometric analysis of early medical publications on Kawasaki-like disease (MIS-C, PIMS-TS) related to SARS-CoV-2.
    Morand A; Urbina D; Giovannini-Chami L; Fabre A
    Arch Pediatr; 2021 Aug; 28(6):464-469. PubMed ID: 34140220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial.
    Andre MC; Sanchez C; Bressieux-Degueldre S; Perez MH; Wütz D; Blanchard-Rohner G; Grazioli S; Schöbi N; Trück J; Welzel T; Atkinson A; Schlapbach LJ; Bielicki J;
    EClinicalMedicine; 2024 Jan; 67():102358. PubMed ID: 38107550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term and medium-term clinical outcomes of multisystem inflammatory syndrome in children: a prospective observational cohort study.
    Glazyrina A; Zholobova E; Iakovleva E; Bobkova P; Krasnaya E; Kovygina K; Romanova O; Blyuss O; Tutelman K; Petrova P; Bairashevskaia A; Rumyantsev M; Korsunskiy AA; Kondrikova E; Nargizyan A; Yusupova V; Korobyants E; Sologub A; Kurbanova S; Suvorov A; Sigfrid L; Buonsenso D; Peroni DG; McArdle AJ; Comberiati P; Munblit D
    Ital J Pediatr; 2024 Jan; 50(1):1. PubMed ID: 38178192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demographic, clinical and laboratory differences between paediatric acute COVID-19 and PIMS-TS-results from a single centre study in the UK.
    Jiju P; Matalliotakis M; Lane S; Wong W; Hedrich CM; Pain CE
    Front Pediatr; 2023; 11():1219654. PubMed ID: 38027272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial.
    Welzel T; Atkinson A; Schöbi N; Andre MC; Bailey DGN; Blanchard-Rohner G; Buettcher M; Grazioli S; Koehler H; Perez MH; Trück J; Vanoni F; Zimmermann P; Sanchez C; Bielicki JA; Schlapbach LJ;
    Lancet Child Adolesc Health; 2023 Apr; 7(4):238-248. PubMed ID: 36746174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-COVID-19 paediatric inflammatory multisystem syndrome: association of ethnicity, key worker and socioeconomic status with risk and severity.
    Broad J; Forman J; Brighouse J; Sobande A; McIntosh A; Watterson C; Boot E; Montgomery F; Gilmour I; Tan J; Fogarty MJ; Gomez X; Cheung R; Lillie J; Shivamurthy V; Handforth J; Miller O;
    Arch Dis Child; 2021 Dec; 106(12):1218-1225. PubMed ID: 33727312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany.
    Sorg AL; Hufnagel M; Doenhardt M; Diffloth N; Schroten H; von Kries R; Berner R; Armann J
    Eur J Pediatr; 2022 Oct; 181(10):3635-3643. PubMed ID: 35962242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [SARS-CoV-2-associated inflammatory multisystem disease in a 15-year-old boy].
    Ormay C; Onozó B; Fitala R; Halász K; Szakos E; Kosztopulosz N; Hauser P
    Orv Hetil; 2021 Apr; 162(16):602-607. PubMed ID: 33830937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee.
    Fernández-Sarmiento J; De Souza D; Jabornisky R; Gonzalez GA; Arias López MDP; Palacio G
    BMJ Paediatr Open; 2021; 5(1):e000894. PubMed ID: 34192188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and Laboratory Biomarkers as Predictors of Severity in Pediatric Inflammatory Multisystem Syndrome-temporally Associated With SARS-CoV-2: Data From a Prospective Nationwide Surveillance Study in Switzerland.
    Wurm J; Uka A; Buettcher M; Kottanattu L; Schöbi N; Trück J; Villiger R; Ritz N; Zimmermann P;
    Pediatr Infect Dis J; 2024 Jul; 43(7):675-681. PubMed ID: 38506504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.